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in-line multi-parametric in vitro cell monitoring
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Future drug discovery and toxicology testing could beneﬁt signiﬁcantly from more predictive and multi-parametric readouts from
in vitromodels. Despite the recent advances in the ﬁeld of microﬂuidics, and more recently organ-on-a-chip technology, there is still
a high demand for real-time monitoring systems that can be readily embedded with microﬂuidics. In addition, multi-parametric
monitoring is essential to improve the predictive quality of the data used to inform clinical studies that follow. Here we present a
microﬂuidic platform integrated with in-line electronic sensors based on the organic electrochemical transistor. Our goals are two-
fold, ﬁrst to generate a platform to host cells in a more physiologically relevant environment (using physiologically relevant ﬂuid
shear stress (FSS)) and second to show efﬁcient integration of multiple different methods for assessing cell morphology,
differentiation, and integrity. These include optical imaging, impedance monitoring, metabolite sensing, and a wound-healing
assay. We illustrate the versatility of this multi-parametric monitoring in giving us increased conﬁdence to validate the improved
differentiation of cells toward a physiological proﬁle under FSS, thus yielding more accurate data when used to assess the effect of
drugs or toxins. Overall, this platform will enable high-content screening for in vitro drug discovery and toxicology testing and
bridges the existing gap in the integration of in-line sensors in microﬂuidic devices.
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INTRODUCTION
In the near future, preclinical testing of new drugs using in vivo
animal models is expected to be entirely substituted by less
expensive, predictive multi-parametric in vitro cell culture
models1–3. Currently, the most common in vitro models are still
based on static cell culture models. Although these models have
made possible signiﬁcant advancements in biological research4,
they have intrinsic limitations due to inadequate mimicking of the
cell microenvironment of tissues and organs, thus inaccurately
representing cell–cell and cell–ECM (extracellular matrix) commu-
nications as well as mechanical and biochemical cues5. To
overcome these limitations, alternative approaches are offered
by three-dimensional (3D) cell cultures6 and, more recently, by
microﬂuidics organ-on-a-chip technology7.
The organ-on-a-chip ﬁeld has witnessed remarkable progress in
the past few years8. The emergence of organ-on-a-chip technol-
ogy provides a valuable new approach to ﬁnely mimic functional
units of a speciﬁc organ using perfusable micron-sized micro-
ﬂuidic devices. Several examples of organ-on-chip devices have
already been described, such as a lung-on-a-chip array9, a human
kidney proximal tubule-on-a-chip10, and a multi-organ-on-chip
device platform for the co-culture of intestine, liver, skin, and
kidney models11. The ﬁeld is fast moving toward the development
of novel and more complex microﬂuidic devices to host these
organoid/tissue models12–18; however, few existing research
efforts have focused on the integration of in-line sensors, for
example, monitoring of cell metabolites, or transepithelial
resistance (TER), within the microﬂuidic environment, while
maintaining compatibility with optical monitoring, despite the
perceived demand19,20.
In-line monitoring systems are in high demand for integration
with in vitro cell culture models, particularly for organ-on-a-chip
devices7,21,22. The coupling of in-line sensors with classical
biological methods can have a tremendous impact on the future
advancement of the ﬁeld, due to the access to real-time
information, without losing the ability to carry out end-point
assays. The use of in-line sensors with in vitro cell models can have
a deep impact on the understanding of cell differentiation,
proliferation, dynamics, and indeed functionality under normal
conditions and when stimulated/challenged with external mecha-
nical and (bio)chemical cues. When comparing discrete assays, for
example, permeability assays, live cell imaging, or reporter assays,
with in-line monitoring systems, their twin limitations are the lack
of temporal resolution and the use of tags or probes. The former
results in the loss of useful information on dynamic changes that
may occur in the system under investigation, while the latter is
both restrictive in terms of available reagents, and may generate
artefacts related to the tag/probe.
As a means of solving these issues, the emerging ﬁeld of
organic bioelectronics23,24 gives access to unique tools for label-
free, real-time sensing that can potentially bridge the existing
gap between rigid, difﬁcult to integrate transducers and soft,
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architecturally complex tissues. Of particular interest at this inter-
face is the organic electrochemical transistor (OECT), a class of
organic devices comprising a thin layer of a conducting polymer
as the active material25. OECTs are three-terminal devices (source,
drain, and gate) in which the conducting layer is deposited
between source and drain, forming the channel of the transistor.
The transistor channel is typically in direct contact with an
electrolyte within which a gate electrode is also present. Poly(3,4-
ethylene-dioxythiophene):poly(styrene sulfonic acid) (PEDOT:PSS)
is a conducting polymer that is commonly employed as the active
layer of OECTs, due to its easy processability, chemical tunability,
and biocompatibility26–28. Solution processability of this material
implies a ﬂexibility of design essential for integration of devices
with state of the art in vitro models, and indeed, incorporation of
microﬂuidics. PEDOT:PSS OECTs have been fabricated on a variety
of substrates, including conformable ones, for interfacing with
tissues in vivo29. The working principle of the OECT relies on the
direct electrochemical doping/de-doping of the PEDOT:PSS from
ions in the electrolyte entering into the active area, upon
application of a gate bias (o0.5 V), thus serving as an efﬁcient
ion-to-electron transducer. OECTs have been employed in a wide
range of applications, ranging from chemo/bio-sensing30,31, to
in vivo brain activity recording29 and in vitro measurements of
barrier tissue integrity32,33 or electrogenic cells34. Similar to the
commercially available cell-based impedance sensing systems
(ECIS, xCelligence), OECTs operating in the AC regime (1 Hz⩽ ƒ
(Hz)⩽ 20 kHz) can also provide information on two of the most
important cell electrical parameters, resistance and capacitance.
OECT technology is also compatible with brightﬁeld and
ﬂuorescence high-resolution microscopy as the PEDOT:PSS active
layer is optically transparent35. Notably, the OECT has also been
demonstrated for highly sensitive and speciﬁc metabolite sensing
from complex media, through biofunctionalization of the gate
electrode26,30,36–38.
Here we demonstrate for the ﬁrst time the coupling of OECTs
with microﬂuidics to achieve a multi-parametric transducer plat-
form as a means to study in vitro models when cultured inside
microchannels. We demonstrate that the microﬂuidics can be
easily fabricated and combined with the OECTs and that laminar
ﬂow can be used to apply a mechanical shear stress to the cells. In
addition to this, we show that the OECTs can monitor changes in
the cell layer capacitance and resistance during ﬂow over an
extended period of time, both under normal conditions and when
exposed to toxins. Moreover, we use the OECT to perform a fully
automated electrical wound-healing assay within the microﬂuidic
device. Combined, this multi-parametric monitoring of live cells in
a physiologically relevant ﬂuidic environment offers great promise
for in vitro toxicology monitoring of live cells.
MATERIALS AND METHODS
OECT fabrication and operation
Thermally evaporated gold source, drain, and gate contacts of the
OECT were deﬁned on a microscope glass slide via liftoff
lithography. Transistor channels of 50 × 50 μm, 100× 100 μm, or
200× 200 μm and gate electrodes (2× 2 mm) were patterned using
a parylene C (PaC) peel-off technique as described previously39.
PEDOT:PSS (Heraeus, Clevios PH1000, Hanau, Germany) conduct-
ing polymer was used as the active layer for the OECT channel and
gate electrode. The conducting polymer formulation consisted of
PEDOT:PSS, ethylene glycol (Sigma-Aldrich, St. Louis, MO, USA,
0.25 mL for 1 mL PEDOT:PSS solution), 4-dodecylbenzenesulfonic
acid (DBSA, 0.5 μL mL− 1) and 3-glycidoxypropyltrimethoxysilane
(GOPS) (10 mg mL− 1). Before use of the OECTs, the microscope
glass slides were soaked in de-ioniwed (DI) water overnight
to wash away any unbound material from the OECT channel
and gate.
For the operation of the OECTs, a National Instruments PXIe-
1062Q system was employed. A source-measurement unit NI PXIe-
4145 was used to bias the channel of the OECT (VDS), while gate
potential was applied and controlled using an NI PXI-6289, a
multifunction data acquisition module. For frequency-dependent
measurements, output currents of the drain (Id) and the gate
(Ig) were recorded using two NI-PXI-4071 digital multimeters. The
bandwidth measurements were performed by applying a
sinusoidal modulation at the gate electrode (ΔVgs = 20 mV peak-
to-peak, 1 Hzo fo20 kHz) while keeping a constant bias at the
drain (VDS =− 0.4 V). Measurements parameters were controlled
using a customized LabVIEW program. For ﬁtting of the frequency-
dependent measurements, a MATLAB script was used to extract
the cell layer resistance and capacitance as reported previously40.
Microﬂuidic fabrication and operation
A multilayer approach for the fabrication of the microﬂuidic device
was employed. Brieﬂy, the microﬂuidic structure was designed
with freeware software (CleWin5) and fabricated using a cutting
plotter (Large Flatbed plotter – FC2250 series) in order to deﬁne
the microﬂuidic channel in a 160 μm thick pressure sensitive
adhesive (PSA) (AR8890, Adhesives Research, Limerick, Ireland). By
peeling off one of the protective layer of the double-sided
adhesive, the PSA was permanently bonded to the substrate by
application of constant pressure over the tape. Subsequently, the
substrate was plasma activated (25 Watt, 2 min) and a
0.3 mg mL− 1 collagen type I from rat tail solution was drop cast
on the substrate. The substrate was then incubated for 30–45 min
at 37 °C in a convection oven to induce crosslinking of the
collagen and physical adsorption of collagen ﬁbers on the
substrate. Physically adsorbed collagen on the plasma-activated
surface promotes the adhesion of cells during cell seeding. At the
end of the incubation time, the substrate was gently rinsed with
warm (37 °C) de-ionized (DI) water and blown dry with nitrogen.
Following collagen functionalization, the PSA microchannel was
permanently sealed using a third layer of a 50 μm thick PMMA
(poly (methyl methacrylate), GoodFellow SARL, Lille, France) in
which inlet and outlet holes were previously obtained with a
2 mm diameter biopsy punch. For the ﬂuidic connections, inlet
and outlet ports were incorporated using a silicone rubber (FDA-
compliant silicone rubber adhesive back, 1/4′′ thick).
Before cell seeding, the fully assembled microﬂuidics, compris-
ing tubing and connection ports, was sterilized with a PenStrep
solution (150 U mL− 1 penicillin, 150 μg mL− 1 streptomycin, pH
7.4, 1 × phosphate-buffered saline (PBS)) for 4 h and then rinsed
with fresh Dulbecco’s modiﬁed eagle’s medium (DMEM) media.
Throughout the experiments, a syringe pump was employed to
achieve continuous perfusion of media in the microchannel.
Experiments were performed in an XL humidiﬁed incubator from
PECON GmbH mounted on a microscope Axio Observer Z1 (Carl
Zeiss MicroImaging GmbH, Oberkochen, Germany).
Cell culture
MDCK II (Madin-Darby canine kidney cells from the distal tube of
the nephron) were cultivated in DMEM (advanced DMEM reduced
serum medium 1, Invitrogen) with 2 mM glutamine (Glutamaxt-1,
Invitrogen, CA, USA), 10% fetal bovine serum (FBS) (Invitrogen),
0.5% PenStrep (PenStrep 100, Invitrogen), and 0.1% Gentamicin
(Gentamicin 100, Invitrogen). For actin cytoskeleton ﬂuo-
rescent-labeled MDCK II-pLifeAct, transfected with pCMV LifeAct–
TagRFP (ibidi GmbH, Martinsried, Germany), the same cell culture
media was used, also including 100 μg mL− 1 of geneticin
(Invitrogen).
For cell seeding, cells grown at ~ 80% conﬂuency in a cell
culture ﬂask were incubated with trypsin (0.25%) at 37 °C for
10–15 min. The collected cells were resuspended in fresh DMEM
media to a ﬁnal concentration of ~ 5 × 106 cells mL− 1. Cells were
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then seeded inside the microﬂuidic channel and let adhere for
30–45 min. Fresh media was then ﬂowed in the microﬂuidics in
order to rinse away the excess of cells. After seeding, cells were
cultivated under constant ﬂow (1.6 μL min− 1) for 3 days in a
humidiﬁed 5% CO2 incubator. On day 3, MDCK II cells form a
conﬂuent barrier with suitable barrier properties (tight junctions).
This corresponds to an OECT impedance spectrum having a
characteristic cutoff frequency of ~ 30–40 Hz (Supplementary
Figure S1). More details can be found in the Supplementary
Information.
Flow shear stress mechanical stimulation
MDCK II and MDCK II-pLifeAct cells were exposed to ﬂowing
culture medium at a ﬂuid shear stress of 0.3 dyne cm− 2 for 15 h
using a syringe pump. Fluid shear stress was calculated using the
equation τ= 6 μQ/bh2, where τ is the shear stress, μ is the medium
viscosity (g cm− 1 s− 1), Q is the volumetric ﬂow (cm3 s− 1), b is the
channel width (cm), and h is the channel height (cm). The
microﬂuidic device was securely ﬁxed on the stage of a
ﬂuorescence microscope. Brightﬁeld and ﬂuorescence pictures of
the barrier were taken every 30 min, while an OECT impedance
spectrum was recorded every 90 min while a constant shear stress
of 0.3 dyne cm− 2 was applied. Following the 15 h of physiologi-
cally relevant ﬂow stimulation, cell layers were kept in culture for a
maximum of 6 h before ﬁxation of the cells on the substrate.
OECT glucose sensor functionalization and sensing
To perform cell glucose uptake quantiﬁcation using the micro-
ﬂuidics efﬂuent, an OECT was used as transducer and ampliﬁer for
enzymatic determination of glucose. Typically, 100 μL of the
exhausted media from the microﬂuidics was collected (every
~ 1 h) in a Eppendorf tube for 3 h prior and 6 h after application of
a physiological relevant ﬂuid shear stress. With regards to the
enzymatic functionalization of the OECT, a PEDOT:PSS planar gate
electrode (600× 600 μm2) was modiﬁed with glucose oxidase
enzyme based on a previously reported method30. Brieﬂy, the gate
electrode was plasma activated (25 W, 2 min) to favor covalent
attachment of a heterobifunctional silane (GOPS) via condensation
reaction. Subsequently, a glucose oxidase/chitosan–ferrocene
(CS–Fc) complex was then immobilized on the GOPS functiona-
lized surface via EDC/NHS chemistry. CS–Fc acts herein as an
electrochemical mediator, thereby enabling electron transport
between the enzyme’s active site and the electrode. Before the
measurements, a standard calibration curve was obtained by
using different dilution ratios of PBS/fresh DMEM media
(Supplementary Figure S2). More details can be found in the
Supplementary Information.
Cytochalasin D assay
A conﬂuent MDCK II-pLifeAct cell layer grown inside the
microﬂuidic channel was exposed to 2 mg mL− 1 cytochalasin D
(Cyt D) while recording impedance spectra and brightﬁeld and
ﬂuorescent images simultaneously. Typically, 100 μL of fresh
DMEM media containing 2 mg mL− 1 Cyt D was allowed to ﬂow
inside the microﬂuidic device from the outlet of the microﬂuidic
and interact with the cell layer for ~ 20 min in static condition.
Following this time, Cyt D free DMEM media was perfused through
the microﬂuidics and recovery of barrier properties was monitored
for ca. 2 h.
RESULTS AND DISCUSSION
Flow shear stress mechanical stimulation
The vast majority of the microﬂuidic platforms published in
literature are fabricated using standard ‘soft lithography’, a
technique based on the fabrication of a silicon mold as a means
to shape a silicone rubber polymer, that is, poly-dimethylsiloxane
(PDMS), with micrometer sized features7. Subsequently, PDMS is
permanently bonded to a ﬂat and smooth substrate, such as glass,
following O2 plasma activation. As a result, irreversible adhesion of
the PDMS microﬂuidic device is achieved and the device can
support long-term operation for days and even weeks.
In the present work, the fabrication of planar OECTs, with both
the transistor channel and the gate electrode patterned onto the
substrate, is performed on conventional microscope glass slides
through liftoff lithography (more details are available in the
‘Experimental’ section). As part of the OECT fabrication, we make
use of a thin layer, ~ 2 μm, of PaC to insulate the gold contact and
deﬁne the active area of the transistor. PaC is one of the many
derivatives of poly(p-xylylene) presenting high mechanical
and chemical stability and it has also found many biological
applications41. However, the presence of PaC as the terminal layer
of the substrate poses severe limitations on the fabrication of
PDMS microﬂuidic devices using standard soft lithography. In fact,
due to the different chemical structures of PDMS and PaC, it is not
possible to achieve permanent bonding of these two substrates
by simple O2 plasma activation. The poor adhesion between the
two substrates results in leaks and, eventually, delamination of the
PDMS structure from the substrate. Some strategies have been
proposed for the irreversible bonding of PDMS and other plastic
substrates42,43, however, on the basis of our initial experiments, it
was not possible to achieve stable adhesion of PDMS and PaC
using these protocols. A possible solution to this can be the
complete removal of the PaC layer from the substrate, making the
glass substrate available for O2 plasma-mediated bonding with
PDMS. However, from an electronic standpoint, the presence of
PaC as the insulator layer is essential for operation of the OECTs.
Indeed, in the absence of PaC, the electrolyte would also be in
direct contact with the source and drain gold contact lines causing
additional capacitive effects that in turn will affect the efﬁciency of
the transistor, as shown in Supplementary Figure S3.
On the basis of these initial observations, and bearing in mind
that the microﬂuidics platform developed has to operate in a
stable manner for several days, we decided to circumvent the PaC/
PDMS adhesion problem by using alternative materials, for
example, acrylic plastic, for the fabrication of the microﬂuidics.
Figure 1a (left) shows a schematic illustration of the developed
platform integrating the OECT and the microﬂuidic device. To
carry out the fabrication of the microﬂuidic device, we made
use of a medical grade double-sided PSA that provides an
irreversible bonding between the PaC insulated OECTs and the
microﬂuidics44.
The proposed platform is made of a single microchannel within
which multiple OECT channels and gate electrodes of different
geometries may be located in the microﬂuidic chamber (W× L×
H= 2.4 mm×6.5 mm×160 μm). The illustration in Figure 1a
(zoom-top) shows a cross-sectional view of the device, in which
the different components are represented, from bottom to top,
the glass/PaC substrate with the OECT channel and gate, the
epithelium and the media perfusing through the microﬂuidic
chamber. Figure 1b shows a picture of the fully assembled device
positioned on the stage of an inverted microscope where the
white layer is the PSA and the adhesive red silicone blocks are
used for the connection of the microﬂuidics with the inlet and the
outlet tubing. Figure 1c also shows a ﬂuorescence image using live
cell imaging (cells expressing an red ﬂuorescent protein (RFP)-
tagged actin) of a fully conﬂuent layer of MDCK II grown inside the
chamber of the OECT/microﬂuidic device.
To establish the appropriate conditions for future experiments,
we ﬁrst investigated the effect of physiologically relevant ﬂuid
shear stress (FSS) on the MDCK II cells when cultured inside the
prepared microﬂuidic device, having the microﬂuidic PSA/PMMA
irreversible bonded to a PaC-coated glass slide. MDCK II are
epithelial cells from the distal part of the nephron in the kidney
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that, under physiological conditions, are exposed to the contin-
uous ﬂow of the glomerular ﬁltrate, ranging between 0.2 and
20 dyne cm− 2 45. To carry out this initial study, we made use of
MDCK II-pLifeAct transfected cells that present ﬂuorescent F-actin
ﬁlaments.
First, MDCK II-pLifeAct cells were cultured inside the microﬂuidic
device under dynamic conditions at a constant ﬂow rate of
1.67 μL min− 1 for ca. 3 days to reach conﬂuency and a typical
cobblestone-like morphology. The constant ﬂow rate guarantees
continuous media turnover thus avoiding cell death due to
depletion of cell nutrients inside the microchannel46. To mecha-
nically stimulate the epithelium with a physiologically relevant
FSS, the ﬂow rate was then increased from 1.6 to 20 μL min− 1. The
latter corresponds to an FSS equal to 0.3 dyne cm−2 (details in the
‘Materials and Methods’ section). These conditions were kept
constant for 15 h while ﬂuorescence time-lapse imaging was
carried out by capturing an image every 30 min. Interestingly, we
observed an increase in F-actin expression (increase in the
ﬂuorescence) induced by the application of a continuous FSS. A
quantitative evaluation of the increase of ﬂuorescence over time is
plotted in Figure 2a (top). As may be appreciated from the graph,
cells started to respond to the ﬂow stimulation within 1 h after
starting FSS. The change in the actin ﬂuorescence expression
becomes more evident over time, reaching its maximum and
stabilising after ca. 12 h. A decrease in the actin ﬂuorescence was
then observed once the ﬂow rate was brought back to its initial
value, however, the overall levels of actin expression remained
elevated compared to initial values. In contrast, cells kept in
culture for the same length of time at 1.67 μL min− 1 (control
Figure 2a) showed no change in actin expression. Time-lapse
images taken during the experiment are shown in Figure 2b (see
also Supplementary Video 1 from ESI). From this simple
experiment, it is clear that cells are sensitive to biomechanical
cues, such as an increase in the FSS, inducing substantial changes
in expression and organization of the cell cytoskeleton proteins.
Here we clearly show in real-time reorganization as well as
increased expression of the F-actin ﬁlaments by simply providing a
more physiologically relevant mechanical shear to the cells. These
observations are consistent with previous studies performed by
Duan et al.47, where FSS induced actin reorganization in renal
proximal tubule cells. Cyclical induction of the F-actin expression
was also observed when cells experienced multiple cycles of
increased and decreased ﬂow rates, as shown in Supplementary
Figure S4.
In addition to the increase in the F-actin expression, for the FSS-
stimulated cells the presence of highly ﬂuorescent F-actin ‘dots’
was observed at the apical side (Supplementary Figure S5iv), as
indicated by the red arrows on the zoom inset image, in contrast
to the images of either the basal side plus FSS (Supplementary
Figure S5iii), or the control cells either basal or apical
(Supplementary Figure S5i and ii). Kidney cells lining the tubular
lumen of the nephron in the kidney present subcellular microvilli
structures to facilitate resorption of salts and nutrients from the
glomerular ﬁltrate. Microvilli are characterized by a dense bundle
of actin ﬁlaments in the core of their structure, that in the ﬂuorescent
images are visible as highly ﬂuorescent dots17,48. Figure 2Ciii
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Figure 1 The integration of microﬂuidics with the OECT for combined optical and electronic monitoring. (a) Graphical representation of the
developed platform integrating the OECT with microﬂuidics. Top right, an illustration of the OECTs and the cell layer lining the bottom surface
of the microﬂuidic channel. Bottom right, top and cross-sectional views of the microﬂuidic device. (b) A picture of a fully assembled
microﬂuidic platform located on a microscope stage, featuring inlet and outlet ports and tubing. The red silicone blocks are used to guarantee
stable connections between the inlet and outlet tubing and the microﬂuidic platform. (c) Fluorescence image of a fully conﬂuent layer of
MDCK II cells transfected with pLifeAct (red ﬂuorescent protein-labeled F-actin) grown inside the microﬂuidic channel integrated with a planar
OECT. The black blocks are the source and drain gold transistor channel contact lines (scale bar, 100 μm). OECT, organic electrochemical
transistor; MDCK II, Madin-Darby canine kidney cells from the distal tube of the nephron.
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shows a confocal image of the cell layer apical surface after FSS
stimulation for 15 h, with discrete areas (bundles) of F-actin clearly
visible, indicating well-deﬁned microvilli structures. In contrast to
this, the apical side of cells in the absence of FSS stimulation
does not present the same morphology, as shown in Figure 2ci.
Another signiﬁcant difference between the two conditions studied
is an almost doubling in the cell height (31.43 ± 0.98 μm compared
to 18.43 ± 2.15 μm), speaking to a better cell polarization upon
application of the FSS. The confocal images allow us to compare
actin at the top of the cells (the aforementioned bundles) with the
very distinct perijunctional actin visible further down the cell
body, (Figure 2Civ). Such differences are not visible in the absence
of FSS, (Figure 2Ci and ii).
Following these initial results and validation of the microﬂuidic
device, we proceeded to the integration of OECTs as in-line
impedance sensors embedded in the microﬂuidics, to allow
electrical monitoring of the optical changes observed. Similar to
the previous section, cells are grown under dynamic conditions
(ﬂow rate equal to 1.67 μL min− 1) to reach conﬂuency, showing a
typical cobblestone-like morphology. Using the OECT, we could
also determine electrically whether the cell layers form a tight
barrier by means of a frequency-dependent measurement
(Supplementary Figure S1)33. Figure 3a shows the temporal
evolution of the cell layer resistance (Rcl) and cell layer capacitance
(Ccl) while cells were exposed to the FSS, using the protocol
described in Figure 2a (bottom).
In parallel with the F-actin ﬂuorescent signal, we also observed
an increase in the cell layer resistance with ﬂuctuations up to
2.25-fold from the initial value, stabilizing to ca. ~ 1.5-fold higher
after 15 h at 0.3 dyne cm−2. The resulting increase in the Rcl can be
attributed to the reassembly of intercellular tight and adherent
junctions due to FSS-induced mechano-transduction47. As further
proof of the increase in the paracellular resistance of the cell layer,
we performed ﬂuorescence immunostaining of the ZO-1 tight
junction protein in order to understand how the reassembly of the
intercellular junctions in the cells takes place. Figures 3bii and iv
show the ZO-1 ﬂuorescence images captured in the two
conditions, when cells are exposed and not exposed for 15 h to
the FSS, respectively. Although in both cases, a certain amount of
ZO-1 protein is present in the cytosol of the cells, it is clear that the
exposure to the FSS induced a signiﬁcant reorganization of the
ZO-1 protein on the borders of the cells. This result suggests that
the monitored increase in Rcl during and after FSS is possibly given
by an increase in the density of the tight junction network, thus
increasing cell layer resistance Rcl as observed from the electrical
measurement in Figure 3a. A more quantitative analysis of the
ZO-1 ﬂuorescence distribution is shown in Figure 3b (right).
The cell layer resistance provides information on the ionic
paracellular pathways, while the cell layer capacitance provides
indirect information on the size and possibly shape of the cell. In
fact, if we assume the cell membrane to be the equivalent of a
capacitor insulator, changes in cell membrane area will affect the
amount of stored electrical charge. The bigger the cell membrane,
the higher the capacitance of the cell layer. In Figure 3a (bottom),
the temporal evolution of the cell capacitance for FSS cells is
shown. A clear increase of the cell layer capacitance is observed
over time with a more stable total increase equal to ~ 1.15-fold,
1 h after the end of the FSS. As the FSS favors the F-actin
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Figure 2 Illustration of the effect of FSS on F-actin expression via time-lapse imaging of cells grown on the platform. (a) The variation in the
actin expression is shown as the relative increase in the ﬂuorescence intensity (λ= 584 nm) induced by physiologically relevant ﬂuid shear
stress (FSS). A conﬂuent layer of epithelial cells (MDCK II-pLifeAct) are grown to conﬂuency under dynamic conditions with a ﬂow rate equal to
1.67 μL min− 1, until cells show a typical cobblestone-like morphology. Once the epithelium is fully conﬂuent, a greater ﬂow rate of
20 μL min− 1 is applied, resulting in an FSS of 0.3 dyne cm− 2, for a total of 15 h of mechanical stimulation of the cells. Below, the FSS/ﬂow rate
proﬁle used for the experiment is represented. (b) Fluorescence images of MDCK II epithelium captured at different time (hh:mm) points,
before (00:30), during (05:00, 10:00, and 15:00) and after (20:00) application of a ﬂow rate equal to 20 μL min− 1 (scale bar, 100 μm). (c) F-actin
confocal images of the apical side (i, iii) and perijunctional section (ii, iv)of a conﬂuent cell layer captured 15 h after exposition at ﬂow rates of
1.67 μL min− 1 (i, ii) or 20 μL min− 1 (iii, iv), the latter corresponding to 0.3 dyne cm− 2 FSS. On the right, cell heights measured by confocal
microscopy in z-sectioned images showing an increase of the cell height due to the FSS (scale bar, 10 μm).
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Figure 3 Multi-parametric readout of epithelial cell response to FSS. (a) Typical in-line monitoring of the cell layer resistance (Rcl) and
capacitance (Ccl) before, during, and after FSS stimulation with a shear stress equal to 0.3 dyne cm
− 2. The cell layer resistance and capacitance
was measured every 90 min during the 15 h of constant FSS (orange area on time axis) and every 20 min for 6 h after FSS stimulation (gray
area time axis). The inset equivalent circuits highlight the two electrical circuit elements, Rcl and Ccl, extracted from the ﬁtting of the equivalent
circuit model. From the equivalent circuit, Rs is the series resistance of the electrolyte and COECT the transistor capacitance (b) F-actin and ZO-1
ﬂuorescence images of a conﬂuent cell layer in the presence and absence of FSS stimulation (scale bar, 10 μm). On the right, the ﬂuorescence
intensity distribution of ZO-1 tight junction protein with and without FSS is shown (n= 10). (c) Uptake of glucose by the MDCK II cell layer
before and after FSS. An increase in the uptake of glucose was observed for cells stimulated with a physiologically relevant shear stress
(20 μL min− 1), while the glucose uptake remains unchanged in the control condition (1.6 μL min− 1). A sample was collected every 1 h from
the microﬂuidic outlet and glucose content was determined using an OECT-based glucose biosensor (n= 3). Error bars show standard
deviation from the mean of three different samples.
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reorganization and expression in the cytoskeleton as well as the
polarization of the cells, the measured increase in the capacitance
may be the consequence of an increase in the cell membrane
surface, that is, cell size and microvilli on the epithelium apical
surface. The electronic measurement of the cell capacitance is in
complete accordance with the formation of microvilli and the
increase in the cell height in case of the FSS stimulation, as
previously shown in Figure 2c.
With respect to the ﬂuctuations observed in the Rcl during the FSS
stimulation (light orange area, in particular for the peaks at time ~5
and ~10 h), this may be correlated to the application of a
mechanical force when a greater ﬂuid ﬂow rate is used, leading
to movements and rearrangement of the cell layer on the substrate.
Mechanisms to explain these changes in the cell impedance for FSS-
stimulated cells may include changes in the cleft height (distance
between substrate and cells) and/or paracellular distance of the
cells49. In the present work, we made use of the equivalent circuit of
Figure 3a (right) to model the cell layer covering the transistor
channel, adding in series to Rs (series electrolyte resistance) and
COECT (transistor channel capacitance), the cell layer resistance (Rcl)
and cell layer capacitance (Ccl) in parallel
40. Notably, the presence of
the cleft height offers an additional ionic resistance (Rcleft) that in our
model is counted in the series electrolyte resistance Rs. Taking these
points into consideration, we posit that the observed Rcl ﬂuctuation
of Figure 3a (top) is attributed to changes in the cell/cell paracellular
distance, due to changes in packing of the cells on the active area of
the transistor channel during high ﬂow. In fact, measured changes
in the impedance spectra were observed in the frequency range
(ƒ(Hz)⩽ 400 Hz) that are commonly attributed to the paracellular
resistance50,51. The aforementioned changes in the Rcl are shown in
Supplementary Figure S6, together with the ﬁtting curves used for
the extrapolation of Rcl and Ccl reported in Figure 3a. It is also
important to note that we ascertained that the ﬂuid ﬂow in
microﬂuidics do not adversely affect the OECT performance, as
shown in Supplementary Figure S7.
Next, we investigated whether the observed variations in actin
expression, resistance, and capacitance were also affecting the
glucose transport of the cells. To determine changes in the cells
glucose uptake, we ﬁrst performed a conventional ﬂuorescence
immunostaining using a GLUT1 glucose membrane transporter
antibody. Differences (see Supplementary Figure S8) in the density
or localization of GLUT1 on the cell membrane when comparing
FSS-stimulated and -unstimulated cells were not apparent. Never-
theless, we sampled the remaining glucose concentration in DMEM
media collected from the microﬂuidic efﬂuent. This analysis can
provide a direct evidence of any changes occurring in the cell
metabolism and uptake of glucose induced by the FSS. Taking
advantage of the facile biofunctionalization of PEDOT:PSS26, we
implemented a glucose electrochemical biosensor based on our
OECTs technology52. Figure 3c shows the glucose uptake of the cells
over time, for samples collected before and after the 15 h of FSS
stimulation at 0.3 dyne cm−2. The glucose uptake is calculated as
the percentage of the ratio between the ﬁnal and the initial glucose
content in DMEM media (Equation (2) supporting S2). As shown in
the graph, there is a clear increase in the glucose uptake for the cells
subjected to high media ﬂow (blue/white points) with a maximum
of ~95% glucose uptake 6 h after the FSS, compared to the more
stable glucose uptake (between ~75 and ~80%) for the control
experiment (red/white points). Increased glucose uptake may be
related to the expression of multiple transporter types and/or better
efﬁciency of the glucose uptake receptors in the microvilli53, and
would be consistent with an increased adsorption of nutrients
allowed by higher surface area at the apical surface.
Electrical wound healing and microﬂuidics toxicity testing
In the previous section, we showed a facile method to achieve
integration of the OECTs with microﬂuidics. One of the key
advantages of using the OECT technology for testing the cells is
the possibility for easy integration of micron-sized electrodes with
a microﬂuidic structure in a compact manner. As further proof of
our capabilities of using the OECTs to perform standard biological
assays, we developed an electric wound-healing assay for the cell
layer cultured in the microﬂuidics. In a classic wound-healing assay
(or scratch assay), cells are grown in a conﬂuent monolayer and
then the layer is ‘wounded’ using a pipette tip or razor blade.
Following the formation of the wound, cells in the proximity of the
wound are monitored over time using a microscope in order to
study their ability to heal and migrate over the damaged area.
However, the scratch assay does not offer a precise control on the
size and the shape of the wounded area. Moreover, it lacks
reproducibility, as the scratch assay is generally a manual
technique. To overcome some of these limitations, Keese
et al.54,55 ﬁrst proposed an alternative method to obtain precise
control of the wound size and shape by using AC electrical
currents to achieve electroporation of cells (wounding) in a well-
deﬁned region corresponding to the area of a micro-sized gold
electrode.
Inspired by these ﬁndings, we developed an electrical wound-
healing assay based on the use of the OECT to generate a wound
in the cell layer covering the transistor channel. As mentioned
before, in a classical scratch assay the healing of the cells is
monitored optically. From a biological stand point, the possibility
to visualize the dynamics behind the healing process provides
information on the speed and vector of healing (and lead to the
elucidation of the purse-string mechanism)56. However, one of the
main limitations on performing wound-healing assay by electrical
means is incompatibility with microscopy as the presence of the
gold electrode at the wound site does not allow for the use of an
inverted microscope. Conversely, OECT technology is fully
compatible with high-resolution microscopy as the PEDOT:PSS
active layer of the transistor channel is optically transparent35. In
this scenario, the use of the OECT to perform an electrical wound-
healing assay can provide a unique tool to overcome the current
limitations on the use of micron-sized gold electrodes, making this
method fully compatible with standard microscopy tools.
Similar to the electrical wound-healing assay developed by
Keese et al., we developed an electrical wound assay using the
OECT channel and the gate electrode in a slightly different opera-
tion mode compared to the classic transistor conﬁguration25, as
shown in Figure 4a (top). The source and drain of the transistor are
shorted together to obtain an equi-potential distribution of the
applied AC voltage in the transistor channel, while a second,
bigger, electrode is used to close the electrical circuit and act as
the counter electrode for the wound generation. It should be
noted that by shorting the source and drain of the OECT channel,
effectively an electrode is generated, which, used together with
the bigger second electrode (gate electrode), was employed for
the generation of the electrical wound in the cell layer. The
alternating potential applied to the system is schematically
represented in the bottom diagram of Figure 4a. For the
generation of the electric wound, a square wave pulse is applied
from zero to the desired voltage (typically below 3 V) at a
frequency of 40 kHz (period of 25 μs). The schematic of Figure 4a
(top) shows the direction of the electric ﬁeld across the two
electrodes in the electrolyte. As the transistor channel is a much
smaller electrode, the potential drop at the electrode/liquid
interface across the cell layer covering this region is above the
critical cell membrane rupturing value (4200 mV)57, resulting in a
localized cell electroporation and lysis, schematically represented
by the gray cells, Figure 4a (top).
For the OECT wound-healing assay, one crucial parameter is
the stability of the PEDOT:PSS organic conducting layer upon the
application of a high oxidative potential needed to induce the
electroporation of the cells. In addition, high potentials (41.1 V) in
an aqueous environment can lead to electrochemical water
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oxidation and formation of other cytotoxic species, such as
chlorine54. Interestingly, the use of AC currents at high frequency
(410 kHz) can easily bypass these undesirable conditions even for
potentials up to 5 V55. Nonetheless, it is well known that the
irreversible electrochemical oxidation of PEDOT:PSS-conjugated
polymer leads to structural changes of the polymer backbone and
loss in its conductivity58. Figure 4b shows the variation of the
maximum transconductance value of the OECT (gm=ΔID/ΔVG)
when sequentially stepping the potential from 0 to 3.4 V at 40 kHz
for 30 s each time, using the electrical conﬁguration and the wave
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Figure 4 A microﬂuidic electrical wound-healing assay with the OECT. (a) Schematic of the experimental set-up of the developed OECT-based
electrical wound-healing assay. A conﬂuent cell layer covering the transistor channel area is electroporated with an oxidative square voltage,
typically below 3 V (bottom schematic), resulting in an electrical wound of the same dimension as the transistor channel. The semicircle lines
represent the electric ﬁeld distribution at the electrode/electrolyte interfaces across the cell layer, while the two gray cells covering the
transistor channel represent the electrically wounded cells. (b) The impact on the OECTmaximum transconductance (gm=ΔID/ΔVG) caused by
the application of oxidative potentials for duty cycles (see equation) equal to 0.3 (green), 0.4 (red), and 0.5 (blue), n= 3. (c) Typical time
evolution of the OECT frequency-dependent response during the healing process of an electrical wound generated on a conﬂuent cell layer of
MDCK II-pLifeAct. A conﬂuent layer of cells grown on the transistor channel induces a shift in the OECT cutoff frequency, from ~1400 Hz
(dashed gray line) to ~ 30 Hz (solid black line). Following the generation of the electrical wound (2.7 V at 40 kHz, duty cycle 0.3, cycle time 30 s),
the cutoff frequency increases (orange line) due to loss of cells from the active area of the device. As the healing of the cells progresses, a
continuous decrease in the cutoff frequency is monitored until completion (blue line). Inset graph shows the sigmoidal evolution in the cutoff
frequency during the healing process. The data point at time zero is omitted for clarity. Below are shown brightﬁeld and ﬂuorescence images
for the pre-wound (black frame), wounded (orange frame), and healed (blue frame) cell layer (scale bar, 50 μm). (d) Electrical wound-healing
assay performed inside the microﬂuidic device. On the top, the temporal evolution of the Rcl during the healing process is shown. The bottom
panel contains the brightﬁeld and the F-actin ﬂuorescence images at different time during the healing process. In the brightﬁeld images, the
red arrows highlight the densely packed healing fronts incorporating the wounded cells and likely leading to the ﬁnal increase of ~ 1.5-fold in
the effective Rcl.(scale bar, 50 μm).
In-line multi-parametric in vitro cell monitoring
VF Curto et al
8
Microsystems & Nanoengineering doi:10.1038/micronano.2017.28
signal shown in Figure 4a. By evaluating the variations in the
maximum transconductance of the OECT, it is possible to obtain
useful information on possible degradation processes induced in
the PEDOT:PSS layer. For a duty cycle of 0.5 (blue line/triangle,
tON = 12.5 μs, tOFF = 12.5 μs), a rapid decrease of the OECT
transconductance is observed for a potential above 1.5 V, resulting
in a total loss of ~ 50% at 3.4 V. To improve the device stability in
this wide potential window, a possible solution is to change the
duty cycle of the squared pulse signal. A shorter duty cycle
reduces the total supplied energy for undesired oxidative
reactions in the conjugated polymer and, at the same time,
allows a longer relaxation of the system. For instance, a duty cycle
of 0.4 (red line/circle, tON = 10 μs, tOFF = 15 μs) slightly improves the
device stability with a total loss of ~ 40% at 3.4 V, while for a duty
cycle of 0.3 (green line/square, tON = 7.5 μs, tOFF = 17.5 μs), the
OECT shows a more stable behavior in the potential window of
interest. In the latter conditions, a ﬁnal ~ 6% decrease in the
maximum transconductance is observed only when the OECT was
sequentially cycled to a potential up to 3.4 V. These ﬁndings are
particularly important as they provide evidence that under these
conditions, that is, 40 kHz, duty cycle 0.3, the OECT channel is
capable of supporting high oxidative potentials without an
irreversible loss in its ampliﬁcation performance, an essential
requirement to perform in-line electrical monitoring of the cell
layer during healing.
Next, we performed the electrical wound-healing assay by
seeding MDCK II-pLifeAct cells on the OECT. Initial optimization
experiments were performed in a classic, static conﬁguration
using a glass well to contain the cell culture media. Figure 4c
shows a typical frequency-dependent transistor response in the
absence (dashed gray curve) and in the presence of a fully
conﬂuent MDCK II-pLifeAct cell layer (black solid line). In the
images below (black frame), the brightﬁeld and the F-actin
ﬂuorescence pictures of a conﬂuent cell layer are shown. The
electrical wound to the cells was then generated by pulsing the
electrode with 2.7 V at 40 kHz (duty cycle 0.3) for 30 s. An identical
pulsing protocol was repeated four times until a complete
absence of ﬂuorescence covering the transistor channel was
observed. The F-actin ﬂuorescence images (orange frame) shows
the well-deﬁned square shape of the wound corresponding to the
size of the transistor channel (100 × 100 μm2), proving the ability
of the OECT to create an electric wound in a well-conﬁned area of
the cell layer. Following the formation of the wound, we then
started to monitor the healing process optically and electronically,
by using the same OECT employed for the generation of the
wounding. Moreover, the electronic monitoring of the healing
process was performed by using the OECT as a three-terminal
device. Figure 4c shows the time evolution of the frequency-
dependent response of the OECT measured every 16 min while
cells were healing, shown by the gradual color change of the
curves from orange (wounded cell layer) to blue (healed cell layer).
As the healing begins, we measured slight variations in the cutoff
frequency arising from the initial rearrangement of the cells in the
proximity of the electrical wound, and formation of two moving
healing fronts (see Supplementary Video 2 ESI). The initial stage of
the healing process corresponds to the closely packed orange
curves of Figure 4c. Subsequently, with the advancing of the
healing fronts toward the middle of the wound a continuous
decrease in the cutoff frequency is observed until completion of
the healing, as revealed by the proximity of the blue curves. The
electrical evolution of the healing process can be appreciated in
more detail in the inset graph of Figure 4c, showing a well-deﬁned
sigmoidal trend with two steady state conditions corresponding
to the start, with a cutoff frequency equal to ~ 600 Hz, and the end
of the healing, with a cutoff frequency equal to ~ 60 Hz, respec-
tively. The images of Figure 4c (blue frame) show the brightﬁeld
and ﬂuorescence images of the fully healed cell layer.
Encouraged by these ﬁndings, we then integrated the OECT
electrical wound-healing assay with the microﬂuidics. Figure 4d
shows the typical time evolution of the cell layer resistance
obtained during the healing process of the cells. First, the cells
were wounded on the transistor channel resulting in a complete
loss of cell-related impedance, as well as the actin ﬂuorescence, in
a well-deﬁned manner, as shown before and in the inset
ﬂuorescence picture at time zero. It is also important to note
from the brightﬁeld image that, following electroporation, dead
cells were still covering the transistor channel area although they
were not responsible for substantial resistive contributions
(Rclo10% of initial value) within the ﬁrst hour of the healing
process. As the healing front of the cells started to move toward
the center of the transistor channel, we measured a continuous
increase in the cell resistance with a ﬁnal Rcl ~ 1.5-fold higher than
the starting resistance before the wound. This can be attributed to
the formation of a densely packed healing front (less permeable to
ions/higher resistance) due to the incorporation of debris from the
dead cells lying on top the transistor channel. This is clearly visible
in the brightﬁeld images collected 1.5 and 3 h after starting of
the healing process as indicated by the red arrows (see
Supplementary Video 3 ESI).
As a ﬁnal demonstration of the platform for drug discovery/
toxicology monitoring, cells were treated with Cyt D. The latter is
part of a class of fungal metabolites that inhibit actin polymeriza-
tion and also induce F-actin depolymerization in the cell
cytoskeleton59. As Cyt D affects the actin ﬁlaments of the cells,
we monitored its effect on MDCK II-pLifeAct cells using the
combined optical and electronic monitoring system. Similar to the
previous section, cells were grown for 3 days at 1.67 μL min− 1 to
reach conﬂuency and expression of appropriate cell-barrier
properties. A DMEM media solution containing 2 μg mL− 1 of Cyt
D was perfused in the microchannel while both brightﬁeld and
ﬂuorescence images were collected and Rcl monitored. Cyt D was
incubated with the cells under static conditions. The ﬂuorescence
image at time zero of Figure 5bi (gray frame) shows a conﬂuent
layer of cells uniformly covering the transistor channel area
(200 × 200 μm2). Figure 5bii and iii shows a zoom of ﬂuorescence
and brightﬁeld images of the cell layer covering the central area of
the transistor channel. Under these conditions, the cells show a
diffuse staining of actin. As the Cyt D starts to disrupt the actin
cytoskeleton (see Supplementary ESI), we observed an abrupt
drop of the cell resistance, that is, 60% decrease in less than 5 min,
as shown in Figure 5a. The ﬂuorescence image of Figure 5ci
captured at t= 20 min shows some changes in the distribution of
the actin in the cells, with the ﬂuorescent actin now predomi-
nantly on the borders of the cells, more clearly visible in Figure 5cii
(green frame). Optical observations are relatively subjective, and
the extent of the barrier damage caused by the presence of Cyt D
is difﬁcult to quantify, especially when comparing the two
brightﬁeld images at t= 0 of Figure 5bii and t= 20 min of
Figure 5cii. In contrast, impedance monitoring using the OECTs
offers a highly sensitive label-free tool to study cell/drug
interaction dynamics in a more exhaustive, direct, and quantiﬁable
manner. In addition, we were also interested to ascertain the
dynamics on the recovery of the barrier properties when the Cyt D
is removed using the microﬂuidics, as shown in Figure 5a. As fresh
cell culture media was perfused inside the microchannel, we ﬁrst
monitored a further 20% decrease of the cell resistance. The drop
in Rcl can be attributed to the mechanical movements of the cells
caused by the initial perfusion of new fresh media in the
microchannel. In fact, as Cyt D acts on the polymerization of the
actin ﬁlaments, we believe that cells lose their plasticity and ability
to support any external mechanical stress, that is, liquid shear.
However, following this initial drop in the cell resistance, a gradual
increase in the Rcl is observed as actin polymerization in the cell
cytoskeleton can resume and cells can recover their healthy
barrier properties. Figure 5d shows images captured at t= 70 min,
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in which the ﬂuorescent actin is predominantly at the periphery of
the cells.
Finally, we also wanted to test the effect that a short exposure
(20 min) to Cyt D can have on the healing of cells. As Cyt D inhibits
the actin polymerization, its presence should adversely inﬂuence
the healing process as cells should not be able to move due to the
depolymerization of the actin ﬁlament in the cell cytoskeleton. As
expected, electrically wounded cells exposed to Cyt D were not
able to form a healing front, and thus heal, when cells were
monitored optically and electronically for over 10 h (see Supple-
mentary ESI). Nevertheless, a completely healed wound was only
observed 24 h after the beginning of the healing process.
CONCLUSIONS
In conclusion, we have developed a simple strategy to integrate a
microﬂuidic platform with a highly sensitive label-free sensor
based on the OECT technology. With the expansion of the organ-
on-a-chip ﬁeld, there is an urgent need for the coupling of these
model organs with more reliable in-line sensors capable of
providing real-time, multi-parametric information on cell integrity.
Since in vitromodels are increasingly being designed for operation
in the range of days to weeks, this poses a signiﬁcant challenge for
adapted monitoring systems. Currently, many organ-on-chip
models are only assessed at the end of the experiment, usually
by disassembly of the device, in a so-called end-point assay10. In
the literature, few examples of impedance electrical monitoring
integrated with organ-on-chip devices have been described19,20,
and the electrode materials employed, for example, silver chloride
(AgCl), are known to be a signiﬁcant source of cytotoxicity if used
for anything other than chronic measurements60. In a recent study
of an in vitro model of the gastrointestinal–microbe interface,
commercially available chopstick electrodes were employed for
the measurement of the cell TER16. However, the insertion of these
electrodes lead to the contamination of the microﬂuidic platform,
thus limiting its employment as a true in-line sensing system, to
say nothing of the issues related to irreproducibility of chopstick
electrode readings32. In literature, other kidney-on-a-chip type of
device have been already reported10,61,62, but except from the
work of Ferrell et al.62 their integration with in-line label-free
sensors was not explored yet. For the latter, however, manual
positioning of Ag/AgCl and silver wires in the microﬂuidics was
needed to locate the recording electrode inside the bioreactor. In
comparison here, we have made use of planar microfabricated
OECTs and an easy strategy for their integration inside the
proposed microﬂuidic platform.
Dual advantages of the use of the OECT used as a multi-
parametric in-line sensor are the biocompatibility of the PEDOT:
PSS active layer (related to hydrogel-like properties)27 as well as a
ﬂexibility to customize the transistor conﬁguration, for example,
planar or vertical geometry with regard to the requirements of the
in vitro model under investigation. Integration of the devices on
ﬂexible substrates has already been demonstrated29 and 3D
electrode formats are in progress63,64. Here we demonstrated the
use of the OECT impedance sensor for the extraction of the cell
layer resistance and capacitance in real time while the epithelium
was stimulated by the biomechanical action of the ﬂuid ﬂow. As
we have demonstrated previously, electronic monitoring provides
more sensitive and quantitative information on conformational
and structural changes occurring to the cells compared to
standard end-point assays, such as immunoﬂuorescence. An
important feature of our platform is the ability to carry out
simultaneous optical monitoring, which validates our data while
providing a benchmark for scientists used to microscopy-based
techniques. The ability to monitor key metabolites using the OECT
is an added beneﬁt, and direct, in situ monitoring of molecules
such as glucose and lactate will be featured in future devices. A
ﬁnal addition to the multi-parametric repertoire is the develop-
ment of a fully automated electrical wound-healing assay, taking
advantage of the transparent nature of the transistor active layer
allowing us to perform live electrical and optical monitoring of the
healing process as it occurred.
In this study, we clearly demonstrate the ability to readily
embed in-line sensors in microﬂuidics, representing the ﬁrst step
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Figure 5 (a) Variation of the cell layer resistance of MDCK II-pLifeAct when exposed to cell culture media containing 2 μg mL− 1 of cytochalasin
D (Cyt D). A large drop in the cell-barrier resistance is visible within the ﬁrst 10 min upon exposure of the cells to Cyt D. When fresh media (Cyt
D free) was re-perfused inside the microchannel, a recovery of cell layer resistance was observed. On the right, the ﬂuorescence images of the
cells (b) before (gray frame), (c) during (green frame), and (d) after (purple frame) exposure to Cyt D are shown (scale bar, 20 μm). On the far
right of the three frames zoom-in ﬂuorescence and brightﬁeld images of the central area of the transistor channel covered with the conﬂuent
cell layer (scale bar, 10 μm) are shown.
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toward a truly integrated platform for the realization of high-
content, high-throughput in vitro testing. Future projects will
concentrate on harnessing the literal ﬂexibility of the conducting
polymer devices shown here for the development of other
platforms, such as multilayer microﬂuidics, to mimic basal and
apical compartments of the cells as well as integration of 3D
electroactive polymer scaffolds.
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